Product Name :
DPI-3290
Description:
DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively。DPI-3290 is one of a series of novel centrally acting agents with potent antinociceptive activity.
CAS:
182417-73-8
Molecular Weight:
487.61
Formula:
C30H34FN3O2
Chemical Name:
3-[(R)-[(2S,5R)-2,5-dimethyl-4-(prop-2-en-1-yl)piperazin-1-yl](3-hydroxyphenyl)methyl]-N-(3-fluorophenyl)-N-methylbenzamide
Smiles :
CN(C(=O)C1=CC(=CC=C1)[C@H](C1=CC(O)=CC=C1)N1C[C@@H](C)N(C[C@@H]1C)CC=C)C1C=C(F)C=CC=1
InChiKey:
LZXRQLIIMYJZDA-UETOGOEVSA-N
InChi :
InChI=1S/C30H34FN3O2/c1-5-15-33-19-22(3)34(20-21(33)2)29(24-10-7-14-28(35)17-24)23-9-6-11-25(16-23)30(36)32(4)27-13-8-12-26(31)18-27/h5-14,16-18,21-22,29,35H,1,15,19-20H2,2-4H3/t21-,22+,29-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.{{Patritumab} MedChemExpress|{Patritumab} JAK/STAT Signaling|{Patritumab} Technical Information|{Patritumab} Data Sheet|{Patritumab} supplier|{Patritumab} Cancer}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.{{Dipotassium glycyrrhizinate} site|{Dipotassium glycyrrhizinate} Anti-infection|{Dipotassium glycyrrhizinate} Technical Information|{Dipotassium glycyrrhizinate} Data Sheet|{Dipotassium glycyrrhizinate} supplier|{Dipotassium glycyrrhizinate} Epigenetics}
Additional information:
DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively。DPI-3290 is one of a series of novel centrally acting agents with potent antinociceptive activity.PMID:23537004 |Product information|CAS Number: 182417-73-8|Molecular Weight: 487.61|Formula: C30H34FN3O2|Chemical Name: 3-[(R)-[(2S,5R)-2,5-dimethyl-4-(prop-2-en-1-yl)piperazin-1-yl](3-hydroxyphenyl)methyl]-N-(3-fluorophenyl)-N-methylbenzamide|Smiles: CN(C(=O)C1=CC(=CC=C1)[C@H](C1=CC(O)=CC=C1)N1C[C@@H](C)N(C[C@@H]1C)CC=C)C1C=C(F)C=CC=1|InChiKey: LZXRQLIIMYJZDA-UETOGOEVSA-N|InChi: InChI=1S/C30H34FN3O2/c1-5-15-33-19-22(3)34(20-21(33)2)29(24-10-7-14-28(35)17-24)23-9-6-11-25(16-23)30(36)32(4)27-13-8-12-26(31)18-27/h5-14,16-18,21-22,29,35H,1,15,19-20H2,2-4H3/t21-,22+,29-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|DPI-3290 (Org 41793) (intravenous; 0.05 mg/kg) produces a 50% antinociceptive response in rats.|Products are for research use only. Not for human use.|